DR. SAMER BALLOUZ (M.D.) – Hematology & Oncology Physician, NPI 1528068020
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
184 MEDICAL ONCOLOGY in MI
Loading map...
Provider Addresses for DR. SAMER BALLOUZ (M.D.)
3577, West 13 Mile Road, Royal Oak, Oakland County, Michigan, 48073, United States
SUITE 204
ROYAL OAK, MI 480736710
Phone: (248) 551-2446
Fax: (248) 551-1094
Mailing address matches the actual address.
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 32 Open Payments records for all available years, with a total value of $1,511.
Total Amount is formed as General ($1,511) + Research ($0) + Ownership ($0) = $1,511.
Last reported payment date: 2024-02-14 • Largest payer in this snapshot: AstraZeneca Pharmaceuticals LP ($525).
Total Amount
$1,511
General + Research + Ownership
Payments
32
Total payment records
General Amount
$1,511
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-02-14
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| AstraZeneca Pharmaceuticals LP | $525 |
| TerSera Therapeutics LLC | $441 |
| Taiho Oncology, Inc. | $69 |
| Mirati Therapeutics, Inc. | $45 |
| Amgen Inc. | $42 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2004-06-29
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20040629000809 | I | Medical Oncology | MI | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 46,920 | 37 | $0 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 18,000 | 13 | $0 |
| J0897 | Injection, denosumab, 1 mg | 11,760 | 28 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,000 | 20 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 8,250 | 18 | $0 |
Insurance plans in this area (ZIP 48073)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| MEDICAL ONCOLOGY | MI | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 489 | 100 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| - | MI | |
| Hematology/Oncology, Internal Medicine | MI | |
| P S Y C H I A T R Y | MI | |
| - | MI | |
| Internal Medicine, Cardiovascular Disease (Cardiology) | MI | |
| Interventional Cardiology, Cardiovascular Disease (Cardiology) | MI | |
| - | MI | |
| - | MI | |
| - | MI | |
| - | MI |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.